Dr. Irvine is a pioneer in applying materials science to immunology. His interdisciplinary work at the intersection of bioengineering, drug delivery, and immunology is consistently at the forefront of its field, with regular publication in Nature, Nature Medicine, Nature Biotechnology, and Science Translational Medicine. He has received an NSF CAREER award and been named to Technology Review’s “TR35.” Dr. Irvine is a founder of Torque Therapeutics.